Entrada Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: TRDA) Delayed: 6.80 +0.38 (5.92%)
Previous Close $6.42    52 Week High
Open $6.49    52 Week Low
Day High $6.81    P/E N/A 
Day Low $6.29    EPS
Volume 291,809